Recent Updates
Recently added Catalysts
ALKS Positive Sentiment

Alkermes Announces Launch of 9th Annual Alkermes Pathways Research Awards® Program

Thursday, September 10, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Alkermes plc has announced the launch of its 9th annual Alkermes Pathways Research Awards program, which will begin accepting applications on September 11, 2026. This competitive grant program aims to support emerging researchers focused on advancing knowledge in neuroscience. The initiative builds on previous cycles to foster innovative research.

Market Sentiment Analysis

POSITIVE FACTORS

  • Supports next-generation researchers in neuroscience.
  • Encourages innovative research in disease understanding.
  • Continues a successful grant program for nine years.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+29%
120-day peak, hindsight
Typical move
3.3%
average across 7 past catalysts
Lead asset
N1539
Phase 2 · Hysterectomy

Full Press Release Details

DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) today announced that it will begin accepting applications for its annual Alkermes Pathways Research Awards® program on Friday, Sept. 11, 2026. Now in its ninth year, this competitive grant program is designed to support the next generation of researchers working on the front lines to advance our understanding of diseases in the field of neuroscience. Building on prior award cycles, the program will continue to accept applications related to s

Frequently Asked Questions

When will the Alkermes Pathways Research Awards accept applications?

Applications for the Alkermes Pathways Research Awards will open on September 11, 2026.

What is the purpose of the Alkermes Pathways Research Awards?

The program aims to support emerging researchers in advancing neuroscience disease understanding.

How many years has the Alkermes research awards program been running?

The Alkermes Pathways Research Awards program is now in its ninth year.

Who can apply for the Alkermes Pathways Research Awards?

The program is designed for next-generation researchers in the field of neuroscience.

ShareAdd on Google
Tags: ALKS Viatris Investor Conferences Healthcare Alkermes research awards neuroscience grant program disease understanding
Last updated: Sep 10, 2026

Biotech snapshot

Cash runway
$691M liquidity · $0M/mo burn
Low dilution risk
Lead asset
N1539Phase 2
Hysterectomy →

Catalyst track record

+29%
best trade around ALKS's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for ALKS.

See every catalyst's timing & PoA →